(HealthDay News) — People with type 1 or 2 diabetes now have a new means of getting their medication, with the U.S. Food and Drug Administration’s approval on Friday of the first inhaled medicine for the blood sugar disease. The drug, Afrezza, “is a new treatment option for patients with diabetes requiring mealtime insulin,” Dr. […]
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
